Skip to main content

Table 3 Comparison of energy expenditure and body composition between patients with breast cancer and controls

From: The effects of chemotherapy on resting energy expenditure, body composition, and cancer-related fatigue in women with breast cancer: a prospective cohort study

Parameter

Cancer (n = 20)

Mean ± SD

Controls (n = 36)

Mean ± SD

p-value

mREE

1596.8 ± 212.1

1421.9 ± 153.1

 < 0.001*

mREE/FFM

34.4 ± 4.8

31.0 ± 3.0

 < 0.001*

mREE/pREE

15.8 ± 9.2

2.5 ± 7.0

 < 0.001*

BW

70.1 ± 5.9

70.4 ± 13.8

0.906

FFMkg

46.6 ± 4.6

46.1 ± 5.4

0.812

FFM%

66.8 ± 6.6

65.1 ± 11.8

0.966

FMkg

24.2 ± 7.2

26.0 ± 13.6

0.915

FM%

33.2 ± 6.6

33.3 ± 8.5

0.497

Effects of 12 weeks of chemotherapy energy expenditure and body composition in patients with breast cancer

Parameter

Baseline (T0; n = 14)

Mean ± SD

Follow-up (T1; n = 14)

Mean ± SD

p-value

mREE

1596.8 ± 212.1

1524.0 ± 230.9

0.174

mREE/FFM

34.4 ± 4.8

33.8 ± 4.2

0.628

mREE/pREE

15.8 ± 9.2

9.8 ± 13.8

0.084

BW

70.1 ± 5.9

71.7 ± 5.2

0.204

FFMkg

46.6 ± 4.6

45.1 ± 3.9

0.006*

FFM%

66.8 ± 6.6

63.6 ± 3.9

0.028*

FMkg

24.2 ± 7.2

25.9 ± 4.0

0.208

FM%

33.2 ± 6.6

39.6 ± 8.6

0.027*

  1. Legend: n, number of participants; mREE, measured resting energy expenditure; pREE, predicted resting energy expenditure; FFM, fat-free mass; BW, body weight; FM, fat mass; significance
  2. *p < 0.05